Atlas Trials

A Retrospective, Observational Study on the Response to Caplacizumab Treatment in aTTP Patients: the Italian Experience (ROSCAPLI)

Clinical trial NCT05785468 · UNKNOWN

Trial details

NCT number
NCT05785468
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status
UNKNOWN
Study type
OBSERVATIONAL
Thrombotic Thrombocytopenic Purpura
Start date
2021-10-21
Primary completion
2023-03-30
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.